Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,734 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,061 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04131192 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | terminated | Phase 1 | 13 | Sunshine Lake Pharma Co., Ltd.INDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT03316222 | Study of GNS561 in Patients With Liver Cancer | terminated | Phase 1 / Phase 2 | 50 | Genoscience PharmaINDUSTRY | 3 | May 2, 2022 | clinicaltrials |
| Ocular Blood Flow in Colorectal Cancer Patients |
| terminated |
| — |
| 11 |
| Medical University of ViennaOTHER |
| 1 |
| Apr 29, 2022 |
| clinicaltrials |
| NCT02866344 | Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases | terminated | N/A | 1 | Wake Forest University Health SciencesOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT02102022 | Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | 140 | Polaris GroupINDUSTRY | 6 | Apr 25, 2022 | clinicaltrials |
| NCT03294252 | Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers(PIPOX) | terminated | Phase 1 / Phase 2 | 34 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT02704130 | TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma | terminated | N/A | 8 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04627142 | A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation | terminated | Phase 1 | 15 | Boehringer IngelheimINDUSTRY | 1 | Apr 20, 2022 | clinicaltrials |
| NCT02588248 | L-Menthol Injection as a Novel Technique During Colonoscopy(MINT-C) | terminated | Phase 3 | 82 | University Hospitals Cleveland Medical CenterOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT01198522 | Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients | terminated | Phase 1 | 28 | Philogen S.p.A.INDUSTRY | 2 | Apr 15, 2022 | clinicaltrials |
| NCT02664077 | A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer(ARGO) | terminated | Phase 3 | 34 | NSABP Foundation IncNETWORK | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03721042 | Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples(OLFADIAG) | terminated | N/A | 68 | Nouvelle Clinique BonnefonOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03165188 | Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy | terminated | — | 29 | NewLink Genetics CorporationINDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT03707028 | A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer | terminated | Phase 1 / Phase 2 | 12 | Elevar TherapeuticsINDUSTRY | 1 | Apr 11, 2022 | clinicaltrials |
| NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer(SENTINEL) | terminated | Phase 1 | 10 | GSO Global Clinical Research BVOTHER | 2 | Apr 8, 2022 | clinicaltrials |
| NCT03396705 | Liver Regeneration | terminated | — | 2 | University Health Network, TorontoOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT03852836 | Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images(BiliFast) | terminated | N/A | 53 | IHU StrasbourgOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT02859415 | Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases | terminated | Phase 1 / Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2022 | clinicaltrials |
| NCT02420795 | Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | terminated | Phase 1 / Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT04555135 | A Clinical Study To Measure The Effect Of Use Of Artificial Intelligence (AI) Enabled Computer Aided Detection (CADe) Assistance Software In Detecting Colon Polyps During Standard Colonoscopy Procedures(ColonCADe) | terminated | N/A | 769 | EndoVigilant IncINDUSTRY | 1 | Apr 1, 2022 | clinicaltrials |
| NCT03300921 | A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer | terminated | Phase 1 | 3 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04258150 | Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer(TRIPPLE-R) | terminated | Phase 2 | 26 | Herlev HospitalOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT03278626 | Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma | terminated | Phase 1 / Phase 2 | 12 | NYU Langone HealthOTHER | 1 | Mar 28, 2022 | clinicaltrials |
| NCT01790035 | Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer(LGG) | terminated | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT03735290 | A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer(ILIAD) | terminated | Phase 1 | 21 | MendusINDUSTRY | 1 | Mar 16, 2022 | clinicaltrials |
| NCT03979547 | EXALT: EXercise Attenuates Liver Tumors Trial(EXALT) | terminated | N/A | 3 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT00447122 | BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer | terminated | Phase 1 | 25 | Brown UniversityOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT01868139 | Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)(ICE-CANCER) | terminated | N/A | 1 | University of Maryland, BaltimoreOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT03784417 | EUS-guided Laser Ablation in Pancreatic Adenocarcinoma | terminated | N/A | 5 | Catholic University of the Sacred HeartOTHER | 1 | Feb 28, 2022 | clinicaltrials |
| NCT04648319 | A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma | terminated | Phase 2 | 1 | American University of Beirut Medical CenterOTHER | 3 | Feb 23, 2022 | clinicaltrials |
| NCT03875313 | Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Calithera Biosciences, IncINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT02982720 | Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron | terminated | Phase 2 | 4 | Aiwu Ruth He, MDOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT03472833 | High-dose Vitamin D3 in Pancreas Cancer(VITdCUT) | terminated | Phase 3 | 25 | Medical University of GrazOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02559024 | Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer | terminated | Phase 1 | 4 | Providence Health & ServicesOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT00321958 | Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer | terminated | — | 23 | University of Maryland, BaltimoreOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | terminated | Phase 1 | 67 | MacroGenicsINDUSTRY | 3 | Feb 8, 2022 | clinicaltrials |
| NCT03099486 | Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC | terminated | Phase 2 | 2 | Fox Chase Cancer CenterOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT01445327 | Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers | terminated | — | 9 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2022 | clinicaltrials |
| NCT02744651 | EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract | terminated | N/A | 4 | Region SkaneOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT03637491 | A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors | terminated | Phase 1 / Phase 2 | 36 | PfizerINDUSTRY | 3 | Jan 26, 2022 | clinicaltrials |
| NCT04034355 | Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer(POLAR-A) | terminated | Phase 3 | 301 | Egetis TherapeuticsINDUSTRY | 10 | Jan 26, 2022 | clinicaltrials |
| NCT00321100 | Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab | terminated | Phase 2 | 23 | Fox Chase Cancer CenterOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | terminated | Phase 1 / Phase 2 | 32 | PharmaEngineINDUSTRY | 1 | Jan 11, 2022 | clinicaltrials |
| NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy(PANTHEON) | terminated | Phase 2 | 67 | AIO-Studien-gGmbHOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT04653389 | Perioperative Therapy for Hepatocellular Carcinoma | terminated | Phase 2 | 10 | Zhejiang UniversityOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT04476329 | Optimization for Regorafenib in HCC(ReDos HCC) | terminated | Phase 2 | 7 | SC Liver Research Consortium, LLCOTHER | 1 | Dec 30, 2021 | clinicaltrials |
| NCT02581709 | An Intervention Programme to Reduce Cognitive Impairment Due to Cancer | terminated | N/A | 15 | Queen's University, BelfastOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT01285102 | Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer | terminated | Phase 1 | 4 | Fox Chase Cancer CenterOTHER | 1 | Dec 20, 2021 | clinicaltrials |
| NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | terminated | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 20, 2021 | clinicaltrials |
Data updated 24 days agoSource updated May 6, 2022source: clinicaltrials